STADA Arzneimittel AG - Strategy, SWOT and Corporate Finance Report

STADA Arzneimittel AG - Strategy, SWOT and Corporate Finance Report

Summary

STADA Arzneimittel AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

STADA Arzneimittel AG (STADA or the company), a subsidiary of Nidda Healthcare GmbH is a provider of pharmaceuticals, generics, and biosimilar products. The company develops and markets drugs with off-patent active pharmaceutical ingredients. It offers portfolio of products in various therapeutic categories including pain, women's health, cardiovascular conditions and diabetes. STADA major generic products include including Tilidin Naloxon, Pantoprazole, Omeprazole, Diclofenac, Amlodipine, Bisoprolol, Olmesartan, Atorvastatin and Epoetin zeta. It also products for cough and cold, skin products, and treatments for head lice, dandruff, sun protection, mounth inflammation, wound healing. The company’s major branded products include Grippostad, SNUP, Aqualor, Vitaprost, Nizoral, Ladival and Covonia. STADA operates across Germany, Central Europe, CIS/Eastern Europe and Asia-Pacific. The company is headquartered in Bad Vilbel, Germany.

Scope

• Detailed information on STADA Arzneimittel AG required for business and competitor intelligence needs
• A study of the major internal and external factors affecting STADA Arzneimittel AG in the form of a SWOT analysis
• An in-depth view of the business model of STADA Arzneimittel AG including a breakdown and examination of key business segments
• Intelligence on STADA Arzneimittel AG's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about STADA Arzneimittel AG, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of STADA Arzneimittel AG and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess STADA Arzneimittel AG as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on STADA Arzneimittel AG's business structure, strategy and prospects.